MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$51.50 2.48 (5.06%)
Open Price: 51.05
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients